Abstract: A bone repair composition and methods thereof include elongated bone fibers made from cortical bone in which a plurality of approximately uniform bone fibers is made into various implant shapes conducive for various applications. The bone fiber compositions may be in the form of a cavity, ball, pellet, wrap, strip, cylinder, cone, putty, gel, or injectable slurry.

Abstract: This invention relates to a novel method of reducing the appearance of rhytides (“facial wrinkles”) and/or infra-orbital shadows (“dark circles”) under the eyes, and striae (“stretch marks”), or lentigo senilis (“age spots”), and hyper/hypo pigmentation on other anatomical areas. Particularly, this invention relates to a topical patch worn on the skin that in a preferred embodiment incorporates two distinct layers, each providing useful features and together providing a novel article and method of improving skin cosmesis. Ease of use, patient comfort and cost effectiveness are provided. The patch is applied to the affected area and preferably worn at least several hours and more preferably worn overnight. The product increases the hydration level of the skin over which it is applied. There is a slight increase to the volume of the local superficial tissue, which serves to tighten the overlying skin and reduce the size and quantity of fine wrinkles at least temporarily.

Abstract: A stabilized bioadhesive composition containing an alkaline labile drug and a method for its preparation are provided. In one aspect, the composition is a hot-melt extruded (HME) composition comprising a preformed excipient mixture comprising an acidic component and an alkaline thermoplastic matrix-forming material, e.g. polymer. The excipient mixture is formed before blending with an alkaline labile drug. The blend is then hot-melt extruded to form the HME composition. By so doing, the acidic component is able to neutralize or render moderately acidic the excipient mixture. This particular process has been shown to substantially reduce the degradation of an alkaline labile drug during hot-melt extrusion. The excipient mixture softens or melts during hot-melt extrusion. It can dissolve or not dissolve drug-containing particles during extrusion.

Abstract: The present disclosure provides antimicrobial compositions including a polyhaloolefin polymer, a cationic antimicrobial agent, and a vehicle that includes a plasticizer and a heat stabilizer. The cationic antimicrobial agent can be partially soluble in the vehicle. The present disclosure also provides for articles formed from the composition, with cationic antimicrobial agent incorporated throughout the polymer matrix, as well as methods of manufacturing the composition.

Abstract: Described herein are compositions and methods for capturing carbonylic or phenolic toxicants, or converting these toxicants into less volatile compounds. The toxicants, which may be a component of cigarette smoke, may be captured by physical or chemical adsorption, absorption, or entrapment.

Abstract: Cleaning compositions including a non-ionic surfactant and a glycol ether are disclosed. These cleaning compositions are useful as liquid cleaners or de-greasers for animate surfaces, such as skin. The cleaning compositions provide improved cleaning and removal of soils without the use of certain VOCs.

Abstract: A method for analyzing an absorbent article may include providing a three-dimensional computed tomography data set comprising a mannequin image and an article image. The article image may be constructed from projections collected while the absorbent article is fitted to a mannequin. An outer surface of the mannequin image may be identified. A desired distance may be provided. A volumetric demarcation may be spaced the desired distance away from the outer surface of the mannequin image. An image volume may be disposed between the outer surface of the mannequin image and the volumetric demarcation. A relevant portion of the article image may be enhanced using a processor. The relevant portion of the article image may be coincident with the image volume.

Abstract: A vehicular instrument panel, including a substrate comprising a plurality of chopped carbon and chopped glass fibers within a nylon resin, the substrate defines an airbag canister. The plurality of chopped carbon and chopped glass fibers are segregated such that the chopped carbon fibers are substantially concentrated within a driver-side portion of the substrate and the airbag canister, and the chopped glass fibers are substantially concentrated within a passenger-side portion of the substrate. The substrate can also include a boundary region such that the plurality of chopped carbon and glass fibers in the substrate are substantially mixed in the boundary region.

Abstract: A vehicular instrument panel having a reinforcement that includes a plurality of chopped carbon fibers within a nylon resin, and a substrate coupled to the reinforcement comprising a plurality of chopped carbon and chopped glass fibers within a nylon resin. The plurality of chopped carbon and glass fibers in the substrate are segregated such that the carbon fibers and the glass fibers are each substantially concentrated within respective driver-side and passenger-side portions of the substrate. The substrate can also include a boundary region such that the plurality of chopped carbon and glass fibers in the substrate are substantially mixed in the boundary region.

Abstract: A vehicular instrument panel having a reinforcement that includes a plurality of chopped carbon fibers within a nylon resin, a substrate coupled to the reinforcement comprising a plurality of chopped carbon and chopped glass fibers within a nylon resin, and a steering column bracket defined from the substrate comprising a plurality of chopped carbon fibers within a nylon resin. The bracket engages a steering column such that the substrate and bracket support the steering column. The plurality of chopped carbon and glass fibers in the substrate can be segregated such that the carbon fibers and the glass fibers are each substantially concentrated within respective driver-side and passenger-side portions of the substrate.

Abstract: Flowable matrix compositions and methods of their use and manufacture are provided. Exemplary compositions may include a flowable, syringeable, putty-like form of acellular human dermal matrix. In some cases, compositions may include a moldable acellular collagen extracellular matrix. In use, the matrix compositions can be used to fill or treat skin voids, channel wounds, and other soft tissue deficiencies.

Abstract: An anti-stick agent and a performance enhancing agent that may be incorporated into an aqueous medium to assist in the prevention of soils and bodily exudates adhering to the skin. A substrate may be utilized to assist in delivering the anti-stick agent and the performance enhancing agent to the skin.

Abstract: The present invention relates to a customized composition comprising three-dimensional (3D) nanofiber webbing. The present invention further relates to the process of producing the composition comprising 3D nanofiber webbing and uses thereof such as treatment of age-related macular degeneration or regeneration/repair of tissue.

Abstract: Methods of using a polymeric composition are described for preventing or reducing the signs of aging. The polymeric composition can include a polymer matrix and one or a plurality of mineral filler(s), uniformly dispersed in the polymer matrix, having properties of absorption and/or emission in the far infrared region ranging from 2 ?m to 20 ?m.

Abstract: The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.

Abstract: A composition having a short disinfecting contact time is disclosed. The composition contains a biguanide or guanide, a quaternary ammonium compound and a basic compound in a specific weight ratio to one another. Compositions having less than a two minute disinfection time are disclosed.

Abstract: A polylactide hydrosol polymer formulations suitable for thin film articles and methods of making the thin film articles are provided. The formulations and methods can be use to make articles such as gloves, condoms, catheters and the like using dip forming, and various casting processes.

Abstract: A fibrous structure. The fibrous structure can be a paper product treated with a waterborne shape memory polymer. The waterborne shape memory polymer can include structural units, wherein each structural unit comprises: a) a switching segment comprising a semicrystalline or amorphous polymer; b) a chargeable unit comprising a cationically or anionically chargeable group; and c) a cross-linkable unit comprising a monomer, wherein the cross-linkable unit connects the switchable segment to the chargeable unit, wherein the waterborne shape memory polymer is dispersible in water.

Abstract: Clothing and covering system with various functions comprising at least one item, having at least one layer, at least one fabric, and at least one function. At least one function is selected from the group consisting of wearing on body, fashion display, preventing snow, preventing wind, preventing sun, preventing dust and dirt, support, comfort, performance, protection, insulation, warmth, coverage, storage, containment, drying, wiping, drainage, security, housing, water flotation, thermal insulation, heat resistance, bullet proofing, sun screening, non ironing, breasts shaping, arch support, seamless footwear, bandaging, cover polarizing, pressure addition, cover planting, electricity generation, food storage with coated paper, odor absorption, aromatherapy, moisturizing, cleansing, dust trapping, glow-in-the-dark, water and leakage proofing, and ingredient addition. Leakproof clothing and covering can control and prevent both leakage of body discharge and secretion, and leakage of rain and water.

Abstract: The present invention is directed generally to a layered polymeric monofilament fiber drug delivery device, where each layer of the device can contain a different polymer, drug, additive, or any combination or mixture thereof. The layered nature of the current monofilament polymeric monofilament device provides the capability to modulate the release of one or more drugs and/or the mechanical properties of the fiber so that drug release and device failure can be separately tuned to provide for the tailored introduction of therapeutically effective drugs or agents to a target tissue. Moreover, the fiber may comprise more than one distinct segments along its length, each segment itself having different combinations and/or numbers of layers thereby providing even greater freedom in the design of the therapeutic delivery device. The invention is also directed to a method of manufacturing such a layered polymeric monofilament fiber drug delivery device, and methods of treatment using such devices.

Abstract: The present invention relates to an insecticide-containing fabric containing at least one embedded insecticidally active ingredient in the polymeric matrix and having excellent wash resistance, and also to the products produced from this fabric and to their use for protecting humans, animals and plants against arthropods, particularly for controlling insects.

Abstract: Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are disclosed. Further disclosed are uses of the antiseptic compositions as disinfectants and in the treatment of wounds.

Abstract: Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are disclosed. Further disclosed are uses of the antiseptic compositions as disinfectants and in the treatment of wounds.

Abstract: Fabrication of yarns or other shaped articles from materials in powder form (or nanoparticles or nanofibers) using carbon nanotube/nanofiber sheet as a platform (template). This includes methods for fabricating biscrolled yarns using carbon nanotube/nanofiber sheets and biscrolled fibers fabricated thereby.

Abstract: A method for the treatment of spider silk filament for use as a thread or composition in the manufacture of cosmetic, medical, textile, and industrial applications, wherein the spider silk filament, derived from genetically modified organisms, is treated with at least one component selected from the group consisting of vitamins, hormones, antioxidants, chelating agents, antibiotics, preserving agents, fragrances, dyes, pigments, magnetic nanoparticles, nanocrystals, cell adhesion enhancers, thermal insulators, shrinkage agents and cosmetic, medical or dermatological active substances. Textile fabrics obtained by this method are stronger, bio-compatible, bio-degradable and have a higher thermal conductivity. Treated spider silk filament can also be applied in an oil-in-water or water-in-oil protective cream that is hypoallergenic and ensures a firmer skin.

Abstract: The present invention relates to method of manufacturing a prytheroid-treated fabric and manufactured products created thereby. Through the development and application of prytheroid nanocapsules to a fabric, the fabric exhibits insecticidal properties, even following successive washings and solar exposure.

Abstract: Wiping products, such as facial tissues, contain a temperature change composition that can provide a cooling sensation when contacted with the skin of a user. The temperature change composition, for instance, can contain one or more phase change agents that undergo a phase change at slightly elevated temperatures. The phase change agents, in one embodiment, can have a relatively high heat of fusion. When undergoing a phase change, the phase change agents absorb heat and thereby provide a cooling feeling to the skin of a user. In one embodiment, the phase change agent comprises a straight chain hydrocarbon. Hydrocarbons useful as phase change agents include an octadecane, a nonadecane, a heptonoate, or mixtures thereof.

Abstract: A tyrosine-based (phosphonylmethoxyalkyl)purine or -pyrimidine conjugate is provided. In some embodiments, the conjugate includes tyrosine based amino acid or dipeptide moieties of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl)adenine or its cytosine analog. A method of synthesizing such conjugates based on Boc-protected amino acid or dipeptides is also provided. In addition, a method of isomerizing an (S,S)-diastereoisomer to an (S,R)-diastereoisomer of an amino acid-based or dipeptide-based conjugate by a process including transesterification is provided. A method of inhibiting viral infection and a method of treating viral infection based on (phosphonylmethoxyalkyl)purine or -pyrimidine conjugates is also provided.

Abstract: An aerosol glitter composition for achieving the “sugar” glitter effect comprises a solvent, binder, square polyester glitter, optionally a rheology modifier, and propellant.

Abstract: The invention provides a cross-linkable composition comprising a saccharide-siloxane copolymer according to a specified structural formula, a crosslinking agent, and, optionally, solvent. Cross-linked polymeric networks, cured coatings, and articles of manufacture formed from the inventive compositions are also provided, as well as processes and methods of manufacturing the inventive cross-linkable compositions and applications thereof.

Abstract: An anti-“Methicillin-Resistant Staphylococcus Aureus (MRSA)” chitosan containing antibacterial High Wet Modulus (HWM) rayon fiber textile for medical usage is made of the steps as following: chitin flakes made from natural shrimp or crab shells are deacetylated to generate chitosan with a high deacetylation degree of 90% or more. Next chitosan is dissolved in acetic acid and regenerated by caustic soda to form a chitosan antibacterial nanoparticles slurry, then added to HWM viscose rayon process, and spinning to produce a chitosan containing antibacterial HWM rayon fiber. The antibacterial amino groups of chitosan and the hydroxyl groups of rayon cellulose combine together via hydrogen bonding. Therefore, the fiber becomes the anti-MRSA antibacterial HWM rayon fiber containing amino groups (—NH3+). Finally the resulting HWM rayon fiber is conducted via a yarn spinning or/and weaving process to procure a medical textile with chitosan content.

Abstract: Methods for treating or preventing neointima stenosis are disclosed. The methods generally involve the use of a TGF? inhibitor, a SMAD2 inhibitor, an FGF Receptor agonist, a Let-7 agonist, or a combination thereof, to inhibit endothelial-to-mesenchymal transition (Endo-MT) of vascular endothelial cells into smooth muscle cells (SMC) at sites of endothelial damage. The disclosed methods can therefore be used to prevent or inhibit neointimal stenosis or restenosis, e.g., after angioplasty, vascular graft, or stent. Also disclosed are methods for increasing the patency of biodegradable, synthetic vascular grafts using a composition that inhibits Endo-MT. A cell-free tissue engineered vascular graft (TEVG) produced by this method is also disclosed.

Abstract: Wiping products, such as facial tissues, contain an interior temperature change composition and an exterior hydrophilic lotion composition that can provide a cooling sensation when contacted with the skin of a user. The temperature change composition, for instance, can contain one or more phase change agents that undergo a phase change at slightly elevated temperatures. The phase change agents, in one embodiment, can have a relatively high heat of fusion. When undergoing a phase change, the phase change agents absorb heat and thereby provide a cooling feeling to the skin of a user. The hydrophilic lotion composition may contain a carrier and a thermo-reversible gelling agent. The hydrophilic lotion composition maintains the temperature change composition within the tissue and helps to prevent skin irritation.

Abstract: The present invention relates generally to the field of prevention of diseases caused by enveloped viruses. More particularly, this invention concerns a composition for inactivating an enveloped virus comprising at least one non phospholipid Lipid Vesicle (nPLV) able to interact with said enveloped virus and an agent that enhances the lipid exchange between said nPLV and the membrane of said enveloped virus.

Abstract: Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C8-C18 fatty acids.

Abstract: In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier.

Abstract: Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an inner coating that includes avenanthramides. By using topical sanitizer that includes avenanthramides before and after wearing gloves, the skin of the person wearing the glove is more exposed to the beneficial avenanthramides all during the workday, not just when wearing gloves. The result is healthier, much softer and more comfortable skin on the hands.

Abstract: Foaming formulations including silicone polyesters are disclosed. These foaming formulations are useful as cleansing formulations such as used in liquid hand cleansers and wet wipes. The foaming formulations provide improved aesthetic properties and foaming appearance, while maintaining high antimicrobial capacity.

Abstract: The present invention provides a hemostatic porous composite sponge comprising i) a matrix of a biomaterial and ii) one hydrophilic polymeric component comprising reactive groups wherein i) and ii) are associated with each other so that the reactivity of the polymeric component is retained, wherein associated means that said polymeric component is coated onto a surface of said matrix of a biomaterial, or said matrix is impregnated with said polymeric material, or both.

Abstract: Polymeric fibers and films that incorporate IR-emitting materials are disclosed. These fibers and films can be loaded with higher concentrations of IR-emitting materials than was previously thought possible. The IR emissivity of the resulting polymeric materials can be enhanced by increasing the surface area of these fibers and films. Laminates of the fibers or films with other substrate layers are also disclosed.

Abstract: Mold-resistant construction materials distinguished by the presence therein of an azole alone or in combination with a sporulation inhibitor and/or with a substance which is antiadhesive with respect to microorganisms.

Abstract: The present invention describes compositions and methods for inhibiting microbial infections associated with the use of sanitary products, such as diapers, bandages, sanitary napkins, tampons, and the like. The present invention comprises providing for use a sanitary product containing an effective amount of a viable, non-pathogenic, lactic acid-producing bacteria, such as Bacillus coagulans, or an extracellular product thereof, useful for inhibiting growth of parasites and pathogens on the epithelial tissue in contact with the sanitary product during use of the product. The present invention also provides for enhancing biodegradation of sanitary products after use and disposal. Also described herein are methods using the product and systems containing the compositions.

Abstract: A self-decontaminating fabric is manufactured from fibers such as Tencel having high surface energy and low surface roughness. Novel scouring methods eliminate substantially all contaminants from the fibers, and a novel coating process applies an anti-pathogen coating such as a halogen compound to the fabric so as to provide rapid deactivation of pathogens on contact. Novel charging methods activate or reactivate the coating, typically by exposure to chlorine. The coating is substantially free of gap regions where pathogens can survive. The high surface energy of the fibers allows a high coating concentration and provides close contact between attached pathogens and the coating. The low surface roughness reduces the pickup of pathogens by the fibers. Multi-layer embodiments include an outer layer configured for maximum anti-pathogen coating concentration, and an inner layer configured for a reduced coating concentration that is compatible with skin contact.

Abstract: Disclosed is a sanitary napkin for wearing adjacent the pudendal region, the sanitary napkin having a skin care composition applied thereon, wherein the sanitary napkin has a caliper less than about 5.0 mm. The skin care composition can have from about 0.001% to about 0.1% by weight of hexamidine, from about 0.001% to about 10% by weight of zinc oxide, from about 0.01% to about 10% by weight of niacinamide, and a carrier.

Abstract: Wiping products, such as facial tissues, contain a temperature change composition that can provide a cooling sensation when contacted with the skin of a user. The temperature change composition includes a phase change material and a non-interfering molecular scaffold. The phase change materials, in one embodiment, can have a relatively high heat of fusion. When undergoing a phase change, the temperature change composition absorbs heat and thereby provides a cooling feeling or cooling sensation to the skin of a user.

Abstract: A silane-QAC-dendritic polymer biocide surface treatment for bath, screen or spray-on application. The silane-QAC-dendritic polymer biocide generally comprises a hyperbranched polymer modified to include functionalized quaternary ammonium for biocidal activity, and further modified to include a functionalized silane moiety to covalently attach the polymer biocide to a variety of substrates through hydrolysis. The hyperbranched polymer may be any one from among a group consisting of dendrimers, dendritic polymers, and hyperbranched polymers, and the functionalized silane moiety may be Siloxane (—Si(OR)3). The resulting surface treatment combines the demonstrated high potency of quaternary ammonium compound dendrimers and hyperbranched polymers with the well-established coupling chemistry of silane functional groups. Upon hydrolysis, the silane groups will covalently attach to functional groups such as amines and hydroxyl groups.

Abstract: The disclosure provides compounds and methods to treat a microbial or a bacterial pathogenesis, and demonstrates that the S. aureus pigment is a virulence factor and potential novel target for antimicrobial therapy.

Abstract: Test methods for assessing irritation of portions of skin are provided. The method may include irritating a portion of skin by contacting the portion of skin with a chemical irritant; irritating the portion of skin by physical irritation; and assessing erythema or dryness of the portion of skin after irritating the steps. Alternatively, the method may include irritating a portion of skin with a chemical irritant; irritating the portion of skin by physical irritation; treating the irritated portion of skin by wiping the irritated portion of skin with a test sample; and assessing erythema or dryness of the portion of skin after the wiping step. A method of irritating a portion of skin to assess one of erythema and dryness may include irritating a portion of skin with a chemical irritant and irritating the portion of skin by physical irritation.

Abstract: This invention relates to deployable hemostatic materials comprising chitosan fibers. The hemostatic materials are suitable for use in sealing or controlling active bleeding from artery and vein lacerations and punctures, and for controlling oozing from tissue.

Abstract: The present invention relates to human metabolism, in particular fat reduction and a cosmetic and pharmaceutical formulation, as well as respective uses in particular together with a dressing material according to the invention.